News
The following is a summary of “Evidence for improved glucose metrics and perinatal outcomes with continuous glucose ...
16h
GlobalData on MSNAbbott US diabetes device sales up 27% amid largely positive Q1Despite major product launches from diabetes rivals last year, Abbott’s diabetes unit brought in $1.8bn total Q1 sales to ...
The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.
Are you worried about how your blood sugar reacts after eating a meal? This has become a hot topic — so much so that numerous companies have released tools to help check your blood sugar after a meal.
DexCom (NasdaqGS:DXCM) recently experienced a 14% price increase over the past week. This uptick coincides with the company's announcement of FDA clearance for the Dexcom G7 Continuous Glucose ...
As per Vantage Market Research, the Global Hba1c Testing Device Market has been significantly growing over the years due to ...
We recently published a list of the 11 Best Penny Stocks to Invest in Under $1. In this article, we are going to take a look ...
Timeslife on MSN44m
Are You Eating Fruit at the Wrong Time?Although fruits are frequently regarded as a nutritious mainstay of any diet, not all fruits are made equal for diabetics.
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased 7.5% from 2022 to $4.9 trillion in 2023.
Abbott Laboratories will make new investments in US manufacturing, with the impact of tariffs on medical devices and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results